AXISBIOTIX LIMITED

Active Newcastle Upon Tyne
1 employees website.com
Healthcare and wellbeing
A

AXISBIOTIX LIMITED

Founded 23 Oct 2019 Active Newcastle Upon Tyne, England 1 employees website.com
Healthcare and wellbeing
Accounts Submitted 8 Apr 2025 Next due 31 Mar 2026 29 days overdue
Confirmation Submitted 27 Oct 2025 Next due 5 Nov 2026 6 months remaining
Net assets £-2M £275K 2024 year on year
Total assets £147K £123K 2024 year on year
Total Liabilities £2M £152K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

The Core Bath Lane Newcastle Helix Newcastle Upon Tyne NE4 5TF England

Telephone

0800 000 0000

Website

www.example.com

Full company profile for AXISBIOTIX LIMITED (12276227), an active healthcare and wellbeing company based in Newcastle Upon Tyne, England. Incorporated 23 Oct 2019. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2020–2024)

Cash in Bank

£29.90k

Decreased by £156.97k (-84%)

Net Assets

-£1.55M

Decreased by £275.05k (-22%)

Total Liabilities

£1.70M

Increased by £152.12k (+10%)

Turnover

£248.34k

Increased by £116.29k (+88%)

Employees

1

Decreased by 1 (-50%)

Debt Ratio

1154%

Increased by 581 (+101%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Simon Jonathan HewitsonDirectorBritishUnited Kingdom5028 Apr 2025Active

Shareholders

Shareholders (1)

Skinbiotherapeutics Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 23 Oct 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

AXISBIOTIX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Mar 2026OfficersAppointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026
13 Feb 2026OfficersTermination of Stuart John Ashman as director on 13 Feb 2026
14 Jan 2026OfficersAppointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026
27 Oct 2025Confirmation StatementConfirmation statement made on 22 Oct 2025 with no updates
30 Sept 2025OfficersTermination of Simon Jonathan Hewitson as director on 30 Sept 2025
20 Mar 2026 Officers

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

13 Feb 2026 Officers

Termination of Stuart John Ashman as director on 13 Feb 2026

14 Jan 2026 Officers

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

27 Oct 2025 Confirmation Statement

Confirmation statement made on 22 Oct 2025 with no updates

30 Sept 2025 Officers

Termination of Simon Jonathan Hewitson as director on 30 Sept 2025

Recent Activity

Latest Activity

Appointment of Mrs Rachel Lisa Parsonage as director on 9 Mar 2026

1 months ago on 20 Mar 2026

Termination of Stuart John Ashman as director on 13 Feb 2026

2 months ago on 13 Feb 2026

Appointment of Mrs Emily Lorraine Bertram as director on 1 Jan 2026

3 months ago on 14 Jan 2026

Confirmation statement made on 22 Oct 2025 with no updates

6 months ago on 27 Oct 2025

Termination of Simon Jonathan Hewitson as director on 30 Sept 2025

7 months ago on 30 Sept 2025